Abstract To determine whether cardiac failure produced by chronic coronary artery stenosis was associated with the activation of myocyte cellular hyperplasia in the myocardium, the changes in number and size of left ventricular myocytes were measured in rats 3 months after surgery. The hypertrophied left ventricle was found to possess 44%, 32%, 49%, and 48% fewer mononucleated, binucleated, trinucleated, and tetranucleated myocytes, respectively. In contrast, the hypertrophied right ventricle contained 1.49x 106 more myocytes as a result of a 2.1-fold, 1.4-fold, and 1.4-fold increase in mononucleated, binucleated, and tetranucleated myocytes. Myocyte cell volume was seen to increase 49% and 21% in left and right ventricular myocytes, respectively. The process of myocyte cellular hyperplasia in the right ventricular myocardium was accompanied by capillary proliferation, and these events were responsible for the parallel addition of newly formed cells and capillaries within the wall and mural thickening. Moreover masked the phenomenon of myocyte cellular hyperplasia in the left ventricle, the presence of DNA synthesis in myocyte nuclei was evaluated at 3 days, 1 week, 2 weeks, 1 month, and 3 months after coronary artery stenosis. Bromodeoxyuridine (BrdU) labeling markedly increased in myocyte nuclei of both ventricles, reaching its peak at 1 and 2 weeks. BrdU labeling of nonmyocyte nuclei also increased but mostly at 2 weeks. To exclude that DNA synthesis was not coupled with ploidy formation, ploidy classes in myocytes were measured by flow cytometry and found not to be increased at 3 months after coronary artery narrowing in both ventricles. In addition, it was documented that mitosis occurred in myocytes and that this process was not associated with a change in the number of nuclei in myocytes. In conclusion, myocyte loss, myocyte cellular hypertrophy, and myocyte cellular hyperplasia all contribute to the development of the cardiomyopathic heart of ischemic origin. (Circ Res. 1994;74:383-400.) Key Words * DNA synthesis * myocyte mitotic division . myocyte number * myocyte size * ploidy formation . cardiac hypertrophy and failure. Impairment of cardiac pump function appears to be a consistent factor for the activation of myocyte proliferation. [4] [5] [6] [7] [8] [9] [10][11] [12] [16] [17] [18] In particular, diastolic Laplace overloading has been shown to be related to this cellular response, whereas modifications of systolic wall stress have a lesser effect on this cellular process.18
t is a general contention that myocardial hypertrophy in the adult heart is accomplished by enlargement of preexisting muscle cells with no cell proliferation. 12 Cardiac myocytes have been claimed to be terminally differentiated cells and have often been compared with neurons for their inability to regenerate and replace damaged myocardium.3 However, observations in humans4-7 and animals8-12 have provided strong supportive evidence that myocyte cellular hyperplasia may occur under a variety of pathological conditions characterized by a large and prolonged stress on the myocardium. In contrast, studies aiming at the identification and quantification of DNA replication in the overloaded myocardium have documented no labeling13 or little DNA synthesis in myocyte nuclei, possibly representing polyploid cells.14-'5 These opposing results may be related to differences in the various animal models and the presence or absence of ventricular dysfunction masked the phenomenon of myocyte cellular hyperplasia in the left ventricle, the presence of DNA synthesis in myocyte nuclei was evaluated at 3 days, 1 week, 2 weeks, 1 month, and 3 months after coronary artery stenosis. Bromodeoxyuridine (BrdU) labeling markedly increased in myocyte nuclei of both ventricles, reaching its peak at 1 and 2 weeks. BrdU labeling of nonmyocyte nuclei also increased but mostly at 2 weeks. To exclude that DNA synthesis was not coupled with ploidy formation, ploidy classes in myocytes were measured by flow cytometry and found not to be increased at 3 months after coronary artery narrowing in both ventricles. In addition, it was documented that mitosis occurred in myocytes and that this process was not associated with a change in the number of nuclei in myocytes. In conclusion, myocyte loss, myocyte cellular hypertrophy, and myocyte cellular hyperplasia all contribute to the development of the cardiomyopathic heart of ischemic origin. (Circ Res. 1994;74:383-400.)
Key Words * DNA synthesis * myocyte mitotic division . myocyte number * myocyte size * ploidy formation . cardiac hypertrophy and failure. Impairment of cardiac pump function appears to be a consistent factor for the activation of myocyte proliferation. [4] [5] [6] [7] [8] [9] [10] [11] [12] [16] [17] [18] In particular, diastolic Laplace overloading has been shown to be related to this cellular response, whereas modifications of systolic wall stress have a lesser effect on this cellular process. 18 Ischemic cardiomyopathy produced by nonocclusive coronary artery constriction is characterized in both humans and animals by chronic loss of myocytes, cardiac hypertrophy, and myocardial scarring that lead to ventricular dilation and increased diastolic wall stress. 19 The functional impairment of the left ventricle may also affect the compliance properties of the right ventricle, and this phenomenon may account for diastolic overload and eccentric right ventricular hypertrophy. Circulation Research Vol 74, No 3 March 1994 during the acute, subacute, and chronic phases of the cardiac myopathy generated by coronary artery constriction in rats.
Materials and Methods Animals
Experiments were carried out in male Sprague-Dawley rats at 2 months of age (Charles River Breeding Laboratories, North Wilmington, Mass). Coronary artery narrowing was performed in 114 animals. Fifty-nine animals in this group died during the 3-month period of experimentation, so 55 rats were included in the study. Twenty-five sham-operated (SO) rats served as controls. Animals were killed from 3 days to 3 months after surgery. Protocol details are described in each specific section.
Coronary Artery Narrowing
Under ether anesthesia, thoracotomy was performed, the left coronary artery located, and a suture positioned around the vessel 1 to 2 mm from its origin. Subsequently, a probe 275 1Lm in diameter was held in contact with the wall of the exposed coronary artery. The entire vessel and the probe were ligated, and the probe was quickly removed. 24 The chest was closed, and the animals were allowed to recover. Shamoperated control rats were treated similarly except that the ligature around the coronary artery was not tied.
Functional Measurements
Just before they were killed, animals were anesthetized with chloral hydrate (300 mg/kg body weight IP), and the external right carotid artery was exposed and cannulated with a microtip pressure transducer catheter (Millar PR 249; diameter, 0.99 mm) connected to an electrostatic chart recorder (Gould ES 2000). After arterial blood pressure was monitored, the catheter was advanced into the left ventricle for the evaluation of left ventricular pressures and dP/dt. Subsequently, a second catheter (Millar PR 249) with a 1200 curved tip was inserted into the right jugular vein and advanced through the superior vena cava and the right atrium into the right ventricular chamber for measurements of right ventricular pressures and dP/dt. Subsequently, rats were respirated on room air. A thoracotomy was performed, and an ultrasonic Silastic flow probe (DBF-110A-CP, 10 MHz, 3.5-mm internal diameter) connected to a pulsed Doppler velocimeter (HVPD-10, Crystal Biotech, Hopkinton, Mass) was placed around the ascending aorta. The flow probe, connected to a pulsed Doppler amplifier operating at 10 MHz, was used in conjunction with the velocimeter to determine cardiac output as previously described.25 26 In Situ Morphometric Studies Quantitative analysis of the myocardium was performed at the 3-month time point only. Twenty-seven coronary-constricted rats and 12 SO control animals were included in this part of the study.
Fixation Procedure
At the completion of the hemodynamic determinations, animals were killed by arrest of the heart in diastole with 1 mL cadmium chloride (100 mmol/L IV). The heart was then perfused through the abdominal aorta at a pressure corresponding to mean arterial pressure.1124 The left ventricular chamber was filled with fixative and kept at a pressure equal to end-diastolic pressure.27 After perfusion with pH 7.2 phosphate buffer for 3 minutes, the coronary vasculature was perfused for 15 minutes with a solution containing 2% paraformaldehyde and 2.5% glutaraldehyde.'1124,27 Subsequently, the heart was excised, and the weights of the left and right ventricles were recorded. The volume of each ventricle was determined by dividing its weight by the specific gravity of muscle tissue, 1.06 g/mL.1", 24, 27 Degree of Coronary Artery Narrowing
The initial 2-to 3-mm segment of the left coronary artery was dissected free, and the luminal diameters of the vessel adjacent to the narrowed site and in the constricted portion were measured with a dissecting microscope. Maximal and minimal internal diameters in each of these two locations were determined at a magnification of x 20, and the geometric mean value was calculated.24 The degree of constriction was evaluated by comparing the vessel diameter above the stenosis with the diameter at the level of the stenosis.
Tissue Sampling
Each heart was sectioned perpendicular to its longitudinal axis. Two adjacent sections, midway between the base and the apex, were obtained to measure chamber luminal diameter and the thickness of the free wall of the left and right ventricles. Eight equally spaced measurements of the left and right ventricular free wall were collected from each slice, and their values were averaged.24 Subsequently, the left and right ventricular free walls were cut into small pieces to obtain approximately thirty 1-mm-thick tissue blocks, which were postfixed in osmium, dehydrated in acetone, and flat-embedded in araldite. These samples were used for the light microscopic estimations of the numerical density of myocyte nuclei, myocyte nuclear length, and electron microscopic morphometry (see below). Two large additional slices of each ventricle were also processed in a similar manner and used for the quantitative light microscopic evaluation of tissue damage in the myocardium (see below). 
Morphometric Determination of Myocyte Damage
The total number of myocyte nuclei in each ventricle, N(n)T, was then derived from the product of the number per unit volume, N(n)v, and the total ventricular volume, VT: analysis was performed in coronary-constricted rats killed 3 days, 1 week, 2 weeks, 1 month, and 3 months after surgery. Three experimental rats were included at each time point, with the exception of the 2-week period, in which four animals were used. Seven SO rats were used as controls.
Flow Cytometry of Myocyte Nuclei
Isolated cardiac myocytes were separated from nonmyocytes by centrifugation through Percoll (Pharmacia Fine Chemicals, Uppsala, Sweden). Approximately 106 cells were suspended in 10 mL of isotonic Percoll (final concentration, 41% in resuspension medium) and centrifuged for 15 minutes at 34g. Populations of myocytes were recovered from the pellet, their purity was evaluated,1112 and they were subsequently treated with hypotonic buffer (0.001 mol/L HEPES, 1.5 mmol/L MgC12, pH 7.4) for 5 minutes; then lysis buffer (3% glacial acetic acid, 5% ethylhexadecyldimethyl ammonium bromide in water) was added, and tubes were shaken every 2 minutes for 10 minutes. By this procedure, myocyte nuclei were fully dissociated from the myocyte cytoplasm.33 Subsequently, nuclei were washed in phosphate-buffered saline by centrifugation (10 minutes,lOOOg), and the nuclear DNA and protein were stained with 10 ,ug/mL diamidino-2-phenylindole and 10 pg/mL sulforhodamine 101 (Eastman Kodak, Rochester, NY) dissolved in 10 mmol/L piperazine-N,N-bis-2-ethanesulfonic acid buffer (Calbiochem, La Jolla, Calif) containing 100 mmol/L NaCl, 2 mmol/L MgCl2, and 0.1% Triton X-100 (pH 6.8), as described. 34 The fluorescence of individual nuclei was measured with an IPC-22 flow cytometer (Ortho Diagnostics, Westwood, Mass) using an appropriate dichroic mirror and emission filter combination to separate the blue fluorescence of the DNA-bound diamidino-2-phenylindole and red fluorescence of proteins counterstained with sulforhodamine 101. The data were stored and analyzed usingACQCYTE (Phoenix Flow Systems, San Diego, Calif) on a Compaq 386 personal computer. The DNA frequency histograms were deconvolved, and the results were computer analyzed with MULTCYCLE software (Phoenix). The percentages of diploid G2 and tetraploid G, nuclei were determined in each preparation. 35, 36 This analysis involved three CAN and three SO rats killed at 3 months after surgery.
Detection of Mitosis
Colchicine was injected intravenously in rats at a dose of 100 mg/kg body weight to arrest cells entering mitosis in metaphase. The changes in the total number of myocyte nuclei in the ventricles are illustrated in Fig 1. In comparison with SO animals, CAN rats exhibited a 32% (P<.0001) loss in the total number of myocyte nuclei in the left ventricle (Fig 1A) . In contrast, the aggregate number of myocyte nuclei in the right ventricle increased 38% (P<.0001) with coronary stenosis (Fig 1B) . Specifically, the left ventricle of experimental animals possessed 14.1 x 106 fewer nuclei than normal hearts, whereas the right ventricle had 2.7x 106 more nuclei than controls. Figs 1C and 1D show the measurements of myocyte cell volume per nucleus in SO and CAN rats. This parameter was not different in the endocardial and epicardial layers of the wall of each ventricle in both animal groups. Therefore, regional values were combined. Coronary narrowing was associated with 49% (P<.0001) and 21% (P<.0001) increases in myocyte cell volume per nucleus in the left and right ventricles, respectively.
In summary, coronary artery constriction of 3 months' duration resulted in myocardial damage, myocyte cell loss, and myocyte cellular hypertrophy in the left ventricle and myocyte nuclear hyperplasia and myocyte cellular hypertrophy in the right ventricle. The availability of myocyte and capillary densities and wall thickness allowed the evaluation of the numbers of myocytes and capillaries included in the wall.27.lAOA' Three months after coronary stenosis, wall thickness increased 31% and the transmural number of myocytes 20% (P<.02) (Fig 2) . Since In summary, coronary artery constriction of 3 months' duration resulted in the parallel addition of newly formed myocytes and capillaries, which, in combination with an increase in myocyte diameter, contributed to the thickening of the right ventricular wall.
DNA Synthesis in Myocyte and Nonmyocyte Nuclei
The morphometric results described above indicated that myocyte nuclear and cellular hyperplasia occurred in the right ventricle after coronary narrowing. However, quantitative analysis of the left ventricle failed to demonstrate an increase in the total number of myocyte nuclei. Conversely, extensive myocardial damage and myocyte cell loss may have masked an actual increase in myocyte nuclei and cells in the left ventricle. Therefore, the incorporation of BrdU in myocyte and nonmyocyte nuclei was measured in both ventricles 3 days, 1 week, 2 weeks, 1 month, and 3 months after surgery.
The light microscopic examination of tissue sections showed that BrdU labeling of myocyte and nonmyocyte nuclei seemed to increase 1 and 2 weeks after coronary narrowing (Fig 3) . Although BrdU labeling of all cell populations decreased with time in CAN rats, stained myocyte nuclei (Fig 4) and nonmyocyte nuclei were observed up to 3 months after surgery. The quantitative results illustrated in Fig 5A involved (Fig SD and Table 1 ). The nonmyocyte cell populations in this ventricle showed a response similar to that seen in the left ventricle. BrdU labeling was maximal at 2 weeks, returning to baseline at 1 month and 3 months.
In summary, coronary artery constriction resulted in a marked increase in DNA synthesis in myocyte and nonmyocyte nuclei that was maximal between 1 and 2 weeks after surgery.
Frequency of Polyploidy in Myocyte Nuclei
The observation that DNA synthesis occurred in myocyte nuclei shortly after coronary narrowing does not document whether this DNA synthetic activity was coupled with mitotic division or ploidy formation. Therefore, the frequency distribution of DNA content was measured by flow cytometry in myocyte nuclei isolated from SO and CAN rats 3 months after surgery. This interval was selected because it corresponded to the period at which the number of myocyte nuclei in the myocardium was examined morphometrically. As illustrated in Fig 6, flow cytometry demonstrated that in control and experimental animals, nuclei with a diploid (2N) amount of DNA constituted the major component of the total population. Tetraploid (4N) nuclei represented a small fraction of the population, whereas other categories of polyploid muscle cell nuclei were not observed. Quantitatively, the percentage of tetraploid myocyte nuclei decreased in CAN rats by 48% (P<.03) in the left ventricle and 33% (P<.04) in the right ventricle (Fig 7) . In contrast, diploid nuclei increased 8Cc (P<.05) and 6% (P<.004) in the left and right ventricles, respectively.
In summary, the DNA synthetic activity of myocyte nuclei after coronary artery narrowing was not coupled with the formation of polyploidy.
Identification of Mitosis in Myocytes
DNA synthesis in myocyte nuclei does not necessarily demonstrate that DNA replication was coupled with nuclear mitotic division. In addition, flow cytometric studies could not distinguish whether tetraploid nuclei represented cells in G, or polyploid cells in G,. Therefore, after colchicine injection, light microscopic sections were examined to detect mitosis in myocytes at 1 and 2 weeks after surgery, since these intervals corresponded to high levels of BrdU labeling in the cells. This was important for the left ventricle because proliferation of myocyte nuclei was not demonstrated on this side of the heart (Fig 1). Fig 8 illustrates metaphase chromosomes in myocyte nuclei of the left ventricle 1 week after coronary narrowing (Fig 8A through 8D) . Similar images were found in the right ventricle (data not shown). In addition, mitotic figures were seen at 2 weeks, 1 month (Fig 9A) , and 3 months after surgery. It should be emphasized, however, that a quantification of this phenomenon was impossible. In most cases, it was extremely difficult to establish whether a mitotic image pertained to a myocyte or a nonmyocyte cell (Fig 9B) . Dividing myocytes lose part of their characteristic appearance, making their recognition very complex.
In summary, myocyte nuclear mitotic division occurred in the left and right ventricles after coronary artery narrowing and persisted with time.
Distribution of Nuclei in Myocytes
The recognition that myocytes can synthesize DNA and undergo nuclear mitotic division does not demonstrate that cellular division occurs. The generation of new nuclei may be coupled with an increased number of nuclei per cell without affecting the number of myocytes. Therefore, the fraction of mononucleated, binucleated, and multinucleated myocytes was measured in SO and CAN rats at 1 week, 2 weeks, 1 month, and 3 months after surgery ( Knowledge of the distribution of nuclei in myocytes (Table 2 ) and the total number of myocyte nuclei in the ventricles (Fig 1) (Fig 10) . Coronary constriction produced 44% (P<.0001) and 32% (P<.0001) losses in mononucleated and binucleated myocytes. Trinucleated cells decreased 49% (P<.005) and tetranucleated cells, 48% (P=NS). In the right ventricle (Fig 11) , mononucleated myocytes increased 110% (P<.0001) 3 months after coronary stenosis. Moreover, binucleated myocytes increased 36% (P<.0001) and tetranucleated myocytes, 38% (P<.02). In contrast, trinucleated myocytes decreased by 31% (P=NS). Finally, the aggregate number of myocytes was decreased 32% (P<.0001) in the left ventricle, whereas the same parameter was increased 40% (P<.0001) in the right ventricle (Fig 12) .
In summary, coronary artery constriction resulted in myocyte loss and myocyte cellular hyperplasia. Discussion
The results of the present study demonstrate that the cellular mechanisms of ventricular remodeling in chronic ischemia involved myocyte loss, myocyte cellular hypertrophy, and myocyte cellular hyperplasia, which together contributed to the development of decompensated eccentric left ventricular hypertrophy. The magnitude of myocyte proliferation in the left ventricle was not sufficient to compensate for the loss of cells, and the consequent reduction in the number of myocytes appeared to be a critical factor in the persistence of ventricular failure and the progression of the disease toward its chronic irreversible phase. In contrast, the increase in aggregate number of myocytes in the right ventricle, in combination with limited myocardial damage, may account for the modest impairment of right ventricular performance in this setting. and in the distribution of nuclei in myocytes. In addition, the decrease in DNA synthesis in myocytes at 1 and 3 months after surgery suggests that the process of cellular hyperplasia was attenuated chronically. However, some proliferation of myocytes may persist because mitotic images in these cells were observed at these late intervals. Quantitative analysis of cell number at 3 months after coronary artery constriction demonstrated that the total number of myocytes in the right ventricle increased 40% as a result of 110% and 36% increases of mononucleated and binucleated myocytes, respectively. In contrast, myocyte proliferation in the left ventricle was not associated with an increase in the total number of myocytes. Myocardial damage and cell loss exceeded the hyperplastic response of myocytes so that the left ventricle possessed 44% and 32% fewer mononucleated and binucleated muscle cells. These losses resulted in a 32% reduction in the number of myocytes in the ventricle.
The data summarized above demonstrate that in 3 months, the right ventricle increased its number of cells by 1.49x The present findings document not only that ventricular myocytes can proliferate but also that this process leads to the restoration of large quantities of muscle cells lost as a result of ischemic injury. This and previous observations8-12,17'8 are consistent with several reports in humans in which myocyte proliferation has been claimed in pathological conditions associated with increases in heart weight in excess of 500 g.4-7 The recognition that myocyte loss is a significant variable of cardiac disease processes, including myocardial aging,"1149 suggests that the critical heart weight theory may have to be reconsidered. Myocyte hyperplasia may be present more frequently than expected and masked by the phenomenon of cell loss."1 Moreover, as demonstrated here, myocyte mitotic division may occur concurrently with cellular hypertrophy and not as a secondary event that takes place after exhaustion of the hypertrophic growth capacity of these cells, as postulated in humans:4 Myocyte Cellular Hypertrophy and Coronary Artery Constriction
Findings in this investigation indicate that myocyte cellular hypertrophy occurred in the left and right ventricles after coronary narrowing. In the left ventricle, a 49% enlargement of myocytes was observed 3 months after coronary stenosis. Myocyte cell volume in the right ventricle increased only 21%. A disproportion existed between the increases in left (12%) and right (68%) ventricular weights and the expansions in myocyte cell volume in the ventricles. This apparent inconsistency reflects the impact of myocyte loss, myocyte cellular hyperplasia, and myocyte cellular hypertrophy on the overall response of the myocardium to chronic ischemia. A similar dissociation between cardiac weight changes and cellular changes has been found with myocardial infarction,41 aging," and hypertension.8-10 These observations document the complexity of the cardiac hypertrophy process and the necessity of measuring myocyte size and number and tissue properties to identify the adaptive and maladaptive components of ventricular remodeling in pathological states.
Ventricular Remodeling and Myocyte Hypertrophy and Hyperplasia
Left ventricular failure after coronary artery constriction was associated with cavitary dilation and a reduction in the thickness of the left ventricular wall. Conversely, right ventricular dysfunction was accompanied by an expansion in chamber volume that was comparable to the increase in mural thickness. Thus, these hemodynamic and anatomic alterations are consistent with eccentric hypertrophy in its decompensated form.50 The phenomenon of maladaptation, however, was much more severe in the left than in the right ventricle. This differential response between the ventricles may find its basis in the inability of left ventricular myocytes to regenerate an adequate number of cells by mitotic division. Myocyte loss can be expected not only to result in an elevation in load on the existing myocytes but also to affect ventricular dimension acutely and chronically. The acute consequences of cell loss reflect the necrotic phase in which dying myocytes are overstretched in diastole and noncontracting in systole,51 resulting in diastolic and systolic wall thinning. The chronic effects include the reparative processes associated with scar formation,52 which also reduce mural thickness and increase cavitary diameter.
The possibility that ongoing myocytolytic necrosis plays a central role in the genesis of chamber enlargement with coronary artery stenosis has been raised previously.24 In addition, myocyte lengthening has been shown to be a component of the hypertrophic response of left ventricular myocytes,23 contributing to the expansion in cavitary volume.3950 Whether structural rearrangement of myocytes within the wall involving side-to-side slippage of cells2753-56 participates in the dilation of the chamber and the development of decompensated eccentric hypertrophy cannot be established here. Similarly, the present results cannot determine whether the phenomenon of myocyte cellular hyperplasia was coupled with the in-series addition of newly formed cells, resulting in an increase in the ventricular chamber volume. 57 The morphometric approach used for the evaluation of the number of myocytes across the right ventricular free wall, their mean center-to-center distance, and their average cross-sectional diameter has allowed the interpretation of the gross anatomic parameters of right ventricular dimension at the cellular level. The 31% increase in wall thickness associated with coronary artery narrowing was the result of a 10% increase in myocyte diameter and a 20% increase in the number of myocytes within the ventricular wall. However, the total number of right ventricular myocytes increased by 40%, which was twofold greater than the increase in the mural number of cells. Thus, myocyte proliferation was associated with the parallel and in-series addition of newly formed cells in the myocardium. This latter form of myocyte growth accounted for the expansion in cavitary volume, documented by the 28% increase in right ventricular wall area.
The pattern of myocyte growth summarized above is consistent with the increase in right ventricular peak systolic and end-diastolic pressures found in the present study. The adaptations of myocytes may be interpreted as a compensatory response of the myocardium at the cellular level that tends to minimize the effects of an increased load on the heart.58 According to the law of Laplace, the larger myocyte diameter and the greater number of cells across the wall would produce a proportional thickening of the wall that should offset the higher peak systolic wall stress resulting from the elevation in pressure. Conversely, the longitudinal insertion of new myocytes would counteract the greater end-diastolic wall stress58 by contributing to the enlargement in chamber volume. In essence, the mechanism of cellular hyperplasia demonstrated here, in which new myocytes were added laterally within the wall and in series in the myocardium, had the beneficial effect of decreasing systolic and diastolic stresses on a per-cell basis, improving the myocardial response to pressure and volume overload hypertrophy.
